SN Nuclearelectrica SA and Framatome have announced the signing of a cooperation agreement to explore the possibility of producing the medical isotope Lutetium – 177 in the Cernavoda nuclear-electrical unit. Lutetium – 177 is used for a variety of treatment for cancer.According to a press release of SN Nuclearelectrica, the initial domain of implementation of the agreement includes a technical feasibility study, based on the Framatome production technology for isotopes, successfully implemented in Canada in 2022.Framatome and Nuclearelectrica will work together to analyse how to maximize the existing infrastructure in Cernavoda in order to produce medical isotopes, besides the clean, safe, reliable, carbon emissions-free energy generated at present.‘In the light of recent evolutions on the market of medical isotopes, the need for safe supply with medical isotopes is growing and, as a result, we consider that this is the right moment to develop projects of medical isotopes production at CNE Cernavoda’ said Cosmin Ghita, CEO Nuclearelectrica.In his turn, Francois Gauche, the manager of Framatome Healthcare stated: ‘We are delighted to have this project with Nuclearelectrica. Mass access to nuclear medicine is closely connected to the development of supply chains on a large scale, reliable and diversified and we want to play a role in the fight against cancer, by helping to the construction of these supply chains. In order to better help the patients in the future, we will need regional nuclear medicine production centres and this project is an excellent opportunity to consolidate the supply chain in Europe’.Nuclearelectrica has 27 years of experience in safe exploitation of the nuclear-electrical unit in CNE Cernavoda, being considered one of the most performing companies in the domain, at global level. Through strategic investment projects (Retechnologisation of Unit1 CNE Cernavoda, development of Unit 3 and 4 CNE Cernavoda, development of SMR project, development of Detritiation Facility) the company wants to supply clean energy, to support the objectives of energy stability and decarbonisation of Romania, to support the Paris Agreement and on the basis of ESG strategy to support the initiatives with impact on human health, similar to this agreement.Framatome Healthcare commits to develop products and services for the health industry. The team supports the value chain of the radioisotopes used in the radiopharmaceuticals for diagnostic imaging and for therapeutical purposes, supplies advanced solutions for complex installations for sterilization, essential for the use of medical materials. The Framatome Healthcare experts promote fight against cancer, develop and support medical apps of the nuclear technology.
Bucharest’s District 4 will soon have 50 new high-power charging stations for electric vehicles, mayor Daniel Băluță announced on Wednesday, July 2. Each station will feature two charging points, allowing up to 100 drivers to charge their vehicles simultaneously. The new infrastructure aims to support the growing adoption of electric mobility in the capital while […]
FintechOS, a leader in financial product management, appointed Sorin Mirea as Vice President of Commercial for Central and Eastern Europe (CEE), effective May. With more than 20 years of experience in the banking industry and a solid transition to the technology sector, he will lead the company’s growth strategy in key markets such as Romania, […]
Ecolet, the B2C brand of the Alsendo Group, has acquired the commercial operations of Curier Online in Romania, marking a significant step in Alsendo’s expansion strategy in Southeastern Europe. The transaction strengthens Ecolet’s position in the local e-commerce logistics market and enhances its technological offering for B2C and C2X clients. Through the deal, Ecolet takes […]
OMRO, the lending branch of the fintech Filbo, together with Filbo Pay and Easybill, listed RON 12.3 million (EUR 2.4 million) in corporate, unsecured bonds on the Bucharest Stock Exchange on July 1. This is OMRO’s fourth issue of corporate bonds. OMRO32 bonds have a nominal value of RON 100 per bond and a variable […]
The Ploiești Court found on Tuesday, July 1, that former tourism minister and influential politician Elena Udrea can be conditionally released from prison. The decision is not final and has reportedly been contested by the National Anticorruption Directorate, or DNA. Udrea is currently hospitalized at the Ploiești County Emergency Hospital, after undergoing surgery on Sunday, June […]
The foreign exchange reserves of the National Bank of Romania, or BNR, totaled EUR 58.281 billion at the end of June 2025, up by 4.71% compared to May 31, 2025. During the month of June, there were inflows of EUR 6.1 billion, representing changes in foreign currency minimum reserves established by credit institutions at the […]
